UAE Approves AstraZeneca's Baxfendy for Hypertension

May 12, 2026

56 min

May 12, 2026 08:30

UAE approves AstraZeneca drug for uncontrolled hypertension

## UAE Leads in Cardiovascular Treatment

The United Arab Emirates has become the first nation globally to approve AstraZeneca's Baxfendy, a new treatment for uncontrolled hypertension. This approval is part of the UAE's strategy to enhance access to advanced medical solutions and improve cardiovascular care.

## Innovative Approach to Hypertension

Baxfendy, containing the active ingredient Baxdrostat, is designed for patients whose high blood pressure remains uncontrolled despite existing treatments. The drug works by inhibiting an enzyme that produces aldosterone, a hormone associated with high blood pressure, thus addressing the root causes of resistant hypertension.

## Clinical Trials and Approval

The approval follows successful outcomes from two Phase III clinical trials, BaxHTN and Bax24, which demonstrated significant reductions in blood pressure when Baxfendy was used alongside standard therapies. This marks a significant advancement in hypertension treatment, reflecting confidence in the scientific data supporting the drug.

## Addressing a Widespread Health Issue

Hypertension is a prevalent chronic condition in the UAE, affecting approximately one in three adults. Despite various treatment options, many patients struggle with uncontrolled blood pressure, highlighting the need for innovative solutions like Baxfendy.

Read the full story at the source

What you need to know to get Emirates ID?

Leave your details and get a guide as a gift to avoid mistakes

Article contents